Get started
Work

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma

Year: 2016
Type: article
Study design: Clinical Trial
DOI: 10.1016/j.clgc.2016.05.010
Authors: Andrea B. Apolo, Fatima H. Karzai, Jane B. Trepel, Sylvia Alarcon, Sunmin Lee, Min-Jung Lee, Yusuke Tomita, Liang Cao, Yunkai Yu, Maria J. Merino, Ravi A. Madan, Howard L. Parnes, Seth M. Steinberg, Beatriz Walter Rodriguez, Ben K. Seon, James L. Gulley, Philip M. Arlen, Nancy A. Dawson, William D. Figg, William L. Dahut
Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Roswell Park Comprehensive Cancer Center, MedStar Georgetown University Hospital, Georgetown Lombardi Comprehensive Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W2407034767
FWCI: 6.965
Cites: 68
Cited by: 54
Related to: 10